Rocket Pharmaceuticals, Inc. (RCKT)
2.18
-0.18
(-7.63%)
USD |
NASDAQ |
Oct 16, 16:00
2.21
+0.03
(+1.38%)
After-Hours: 20:00
Rocket Pharmaceuticals Cash from Operations (Quarterly) : -39.61M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -39.61M |
| March 31, 2026 | -45.39M |
| December 31, 2025 | -34.84M |
| September 30, 2025 | -50.43M |
| June 30, 2025 | -48.98M |
| March 31, 2025 | -55.80M |
| December 31, 2024 | -46.96M |
| September 30, 2024 | -52.13M |
| June 30, 2024 | -53.85M |
| March 31, 2024 | -56.88M |
| December 31, 2023 | -29.37M |
| September 30, 2023 | -57.18M |
| June 30, 2023 | -50.91M |
| March 31, 2023 | -57.60M |
| December 31, 2022 | -56.06M |
| September 30, 2022 | -43.90M |
| June 30, 2022 | -39.08M |
| March 31, 2022 | -39.27M |
| December 31, 2021 | -29.50M |
| September 30, 2021 | -27.87M |
| June 30, 2021 | -39.77M |
| March 31, 2021 | -24.22M |
| December 31, 2020 | -17.10M |
| September 30, 2020 | -17.82M |
| June 30, 2020 | -22.88M |
| Date | Value |
|---|---|
| March 31, 2020 | -22.40M |
| December 31, 2019 | -19.73M |
| September 30, 2019 | -10.85M |
| June 30, 2019 | -18.10M |
| March 31, 2019 | -15.98M |
| December 31, 2018 | -20.81M |
| September 30, 2018 | -11.64M |
| June 30, 2018 | -9.738M |
| March 31, 2018 | -11.60M |
| December 31, 2017 | -5.989M |
| September 30, 2017 | -4.094M |
| June 30, 2017 | -2.156M |
| March 31, 2017 | -3.723M |
| December 31, 2016 | -11.14M |
| September 30, 2016 | -9.132M |
| June 30, 2016 | -8.003M |
| March 31, 2016 | -8.993M |
| December 31, 2015 | -7.039M |
| September 30, 2015 | -4.327M |
| June 30, 2015 | -4.057M |
| March 31, 2015 | -1.993M |
| December 31, 2014 | -2.994M |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | -1.855M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 197.07M |
| Intellia Therapeutics, Inc. | -83.11M |
| Beam Therapeutics, Inc. | -66.10M |
| Arrowhead Pharmaceuticals, Inc. | -177.47M |
| Oncolytics Biotech, Inc. | -8.066M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 214.36M |
| Cash from Financing (Quarterly) | 0.15M |
| Free Cash Flow | -170.40M |
| Free Cash Flow Per Share (Quarterly) | -0.346 |
| Free Cash Flow to Equity (Quarterly) | -39.66M |
| Free Cash Flow to Firm (Quarterly) | -39.18M |
| Free Cash Flow Yield | -69.48% |